Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

Core Insights - Century Therapeutics is a biotechnology company focused on developing induced pluripotent stem cell (iPSC)-derived cell therapies targeting autoimmune diseases and cancer [2] Company Participation - Century Therapeutics will participate in the Piper Sandler 37th Annual Healthcare Conference in New York, with a live webcast available on the company's Investors page [1] - An archived replay of the webcast will be accessible for at least 30 days following the event [1] Leadership Engagement - Chad Cowan, Ph.D., Chief Scientific Officer, will join the "State of the Art in Cell Therapy" panel discussion on December 2, 2025 [3] - Brent Pfeiffenberger, Pharm.D., Chief Executive Officer, and Dr. Cowan will participate in a webcasted fireside chat on December 3, 2025 [3] Technology and Approach - The company utilizes its iPSC cell foundry and the Allo-Evasion™ technology to develop off-the-shelf cell therapies, aiming to enhance patient access and improve upon existing therapies [2]